NextPlat vs SurgePays
NXPL and SURG side by side, both in telephone communications. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NXPL and SURG compare
NextPlat is the larger company, worth 2.6 times as much as SurgePays ($18.8M against $7.4M).
NextPlat scores higher on the StockData Score (8 against 1 for SurgePays), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NXPL | SURG |
|---|---|---|
| Size and price | ||
| Market cap | $18.8M | $7.4M |
| Share price | $6.94 | $0.139 |
| Change, 1 year | 2.7% | −93.1% |
| Change, 5 years | −83.9% | −94.3% |
| Beta (5Y) | 1.20 | 2.49 |
| Employees | 121 | 30 |
| StockData Score | ||
| Total score | 8 (better) | 1 |
| Valuation score | 3 (better) | 1 |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 3 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.4× | 0.1× (better) |
| P/B | 1.1× | – |
| FCF yield | −24.2% | – |
| Fair value | $12.07 | – |
| Margin of safety | 42.5% | – |
| Growth | ||
| Revenue growth (TTM) | −17.8% | – |
| Revenue growth, 5Y average | 57.0% (better) | 0.92% |
| Profitability | ||
| Gross margin | 26.2% (better) | −19.6% |
| Operating margin | −14.3% (better) | −41.0% |
| Net margin | – | −47.9% |
| FCF margin | −9.5% | – |
| Return on invested capital | −83.7% | – |
| Financial health | ||
| Debt / equity | 0.05 | – |
| Interest coverage | – | −15.3× |
| Current ratio | 2.29 (better) | 0.19 |
| Altman Z-score | −0.59 (better) | −21.51 |
| Piotroski F-score | – | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 4.8% | 4.4% |
| Held by insiders | – | 9.2% |
| Insider net buying, 12 months | – | $83.0K |
| Short interest, % of float | – | 9.1% |
Go deeper
- NXPL stock overview
- NXPL income statement
- NXPL valuation and score
- SURG stock overview
- SURG income statement
- SURG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.